The aim of this study was to investigate the phenotypic plasticity of pancreatic islets of Langerhans. Quiescent adult human islets were induced to undergo a phenotypic switch to highly proliferative duct-like structures in a process characterized by a loss of expression of islet-specific hormones and transcription factors as well as a temporally related rise in the expression of markers of both duct epithelial and progenitor cells. Short-term treatment of these primitive duct-like structures with the neogenic factor islet neogenesisassociated protein ) induced their reconversion back to islet-like structures in a PI3-kinase-dependent manner. These neoislets resembled freshly isolated human islets with respect to the presence and topological arrangement of the four endocrine cell types, islet gene expression and hormone production, insulin content and glucoseresponsive insulin secretion. Our results suggest that adult human islets possess a remarkable degree of morphogenetic plasticity. This novel observation may have important implications for understanding pancreatic carcinogenesis and islet neogenesis.
Introduction
In the adult human pancreas, the endocrine cells comprising the islets of Langerhans have traditionally been considered a quiescent population of terminally differentiated cells 1 that are derived from primitive duct-like structures during pancreatic organogenesis. 2 In contrast, ductal and acinar cells that comprise the remainder of the pancreas appear to exhibit phenotypic plasticity. [3] [4] [5] [6] However, emerging evidence now suggests that adult islets may also be capable of morphogenetic transformation. [7] [8] [9] [10] [11] In this regard, it is noteworthy that phenotypic changes in isolated adult islets both after isolation and following transplantation have been associated with their failure to restore normoglycemia. 12, 13 Moreover, islet-to-duct transformation has been suggested to play a critical role in the development of pancreatic adenocarcinomas, the most common type of pancreatic cancer, where the cell of origin still remains elusive. 9, 14 While the cellular and molecular mechanisms that control islet phenotype in the adult human pancreas remain poorly understood, it is possible that these mechanisms may be those known to direct the development and phenotypic maturation of functional islets during pancreatic morphogenesis. In this regard, the transcription factor pancreatoduodenal homeobox gene-1 (PDX-1), which is critical for pancreatic development, 15 is also a key regulator of a number of factors that define and maintain islet cell phenotype and function including insulin, 16 glucokinase 17 and glucose transporter-2 (GLUT-2). 18 PDX-1 has been associated with islet progenitors in both the developing 21, 22 and the regenerating adult pancreas, 23, 24 and is activated by phosphorylation by extracellular-regulated kinase-1/2 (ERK-1/2) 19 and Akt, 20 which is in turn under the control of phosphatidylinositol 3 0 -kinase (PI3-K). Likewise, nestin 25 and the transcription factor neurogenin-3 (NGN-3) 21, 26, 27 have also been proposed as markers of endocrine precursor cells as they are expressed in putative islet progenitors in the pancreatic epithelium prior to their endocrine differentiation. NGN-3 expression is regulated by intracellular signaling molecules including Akt 28 as well as signal transduction pathways activated by members of the Notch and wingless-type MMTV integration site (WNT) families, 29 which initiate signaling events that culminate in the development and maintenance of progenitor cell populations in several tissues. [30] [31] [32] [33] During pancreatic morphogenesis NGN-3 participates in the induction of transcription factors that are involved in the development of a mature islet phenotype including islet-1 (ISL-1), NeuroD/Beta2 and NK homeobox gene 2.2 (NKX-2.2). 34, 35 However, the existence of a static population of functionally undifferentiated progenitors cells in the adult pancreas remains controversial. 2, [36] [37] [38] [39] [40] [41] Taken together, various intracellular signaling molecules and transcription factors have been proposed to control the phenotype of tissues in the developing pancreas, but their role in the adult pancreas remains to be confirmed.
In an effort to explore the morphogenetic plasticity of isolated islets, we developed an in vitro model of adult islet-toduct transformation. 8, 10, 11 In this model, freshly isolated islets of Langerhans, which are solid spheroid structures, undergo cavitation as they are induced to transform into duct-like epithelial cystic structures (DECs) comprised of a single layer of highly proliferative duct-like epithelial cells that no longer express endocrine characteristics. This phenotypic switch occurs through a highly orchestrated two-step mechanism involving extensive cell death accompanied by a change in phenotype of the remaining cells. 11 These two steps appear to be regulated in part by a relative balance in signaling activities between c-Jun N-terminal kinase-1/2 (JNK-1/2) and caspase-3 versus ERK-1/2 and Akt. This result is in keeping with the prevailing notion that the dynamic balance between activities in these signal transduction pathways is a critical determinant of cell phenotype, proliferation and apoptosis. [42] [43] [44] [45] The aim of the current study was to investigate the possibility that these islet-derived duct-like structures contain regeneration-competent cells 46 that could be manipulated to produce new islets. We now report that adult human isletderived DECs express putative progenitor cell markers and that these cystic structures can be induced to form new islets that resemble freshly isolated islets in morphology and cellular architecture, gene expression, insulin content and glucose-regulated insulin secretion. This model may therefore be useful for the identification of factors and mechanisms that control adult human pancreatic islet plasticity and regeneration.
Results

Islet-to-DEC transformation
Freshly isolated adult human islets of Langerhans were characterized by immunohistochemistry (IHC). Insulin þ bcells comprised the majority of the islet tissue (B85%, Figure 1a ), whereas glucagon þ a-cells, somatostatin þ dcells and pancreatic polypeptide þ PP-cells formed a mantle layer surrounding the inner b-cell mass of the islets, together accounting for approximately 15% of the islet tissue (Figure 1b) . When embedded in a type I collagen gel matrix and cultured in a defined medium, the islets underwent a phenotypic transformation back into primitive DECs within 10 days, as observed by inverted microscopy ( Figure 1c ). These structures were cystic in appearance, differing substantially from the solid morphology of the starting islets. DECS were comprised of a single layer of cuboidal and low columnar epithelial cells (Figure 1d, day 10) .
Immediately following isolation, islets expressed high levels of endocrine hormones and transcription factors and minimal levels of duct epithelial markers including cytokeratin-19 (CK-19) and carbonic anhydrase-II (CA), as determined by semiquantitative real-time polymerase chain reaction (sqRT-PCR) (Table 1) or IHC (Figure 1d, day 0) . Conversely, the expression of duct epithelial markers increased upon DEC formation, while there was a decrease in the expression of endocrine hormones and transcription factors including NKX-2.2 and ISL-1 (Table 1, Figure 1d , day 10).
DECs originate from islet mantle cells
Unlike central necrosis, which can occur after prolonged islet culture, 47 the cavitation occurring in islet-to-DEC transformation involves apoptosis and can be blocked by inhibition of JNK-1/2 phosphorylation or caspase-3 cleavage. 11 In order to confirm the presence of apoptosis in the current human model, we employed a programmed cell death-specific enzyme-linked immunosorbent assay (ELISA). We determined that the period of transformation from islet-to-DEC was In order to identify which cells of the islet mantle may give rise to the DECs, colabeling for islet cell hormones and CK-19 was performed by IHC. In transitional structures (i.e. islets with evidence of early phenotypic transformation), CK-19 colocalized with glucagon or somatostatin in cells of the mantle region of the islet but not with insulin ( Figure 2c ). In addition, ultrastructural studies demonstrated the appearance of individual cells with both endocrine (endosecretory granules) and epithelial (microvilli) cytologic features at the same time point (Figure 2b ). Taken together, these observations reinforce the notion that the mantle cells of the islet contribute to DEC formation, while the b-cell core of the islet selectively undergoes apoptosis. progenitor cells in the DEC, 23, 24, 53 as does the increased expression of nestin and NGN-3 (Table 1, Figure 3d ).
21,25-27
DECs can be transformed back to islet-like structures (ILS)
Based on the aforementioned morphogenetic characterization of DECs, we hypothesized that they could be induced to redifferentiate back to fully functional islets. To test this notion, DECs from day 10 of culture were incubated with the putative islet neogenic agents glucagon-like peptide-1 (GLP-1), 54 its long-acting analog exendin-4 55 or a 15-amino-acid peptide derived from the active portion of islet neogenesis-associated protein (Figure 4f ).
ILS are morphologically and functionally similar to isolated islets
In comparison to the DECs from which they developed, ILS are characterized by the reappearance of islet hormones ( In addition to islet cell hormones and their genes, ILS also express the islet-associated transcription factors PDX-1, ISL-1 and NKX-2.2 at levels comparable to freshly isolated adult human islets (Table 1) . By IHC, 88.575.3% of all cells in the ILS contained PDX-1 (Figure 5a ), while 12.471.0% of Figure 5b ) at day 14. In addition, GLUT-2 and Cpeptide (a cleavage product of proinsulin released during insulin production) were localized to the ILS core ( Figure 5c and d, respectively). Taken together, these data strongly suggest that the DEC-to-ILS transformation process appears to be transcriptionally regulated by factors implicated in islet development that normally occurs in vivo. 29, 53 Given that PDX-1 is required for proper physiologic islet function, 59 and that the presence of GLUT-2 and C-peptide suggests normal insulin processing and secretion, 60 we hypothesized that ILS process and secrete insulin in a physiologic manner. To test this hypothesis, we assessed insulin content and glucose-stimulated insulin secretion in freshly isolated adult human islets, DECs and ILS by ELISA. While DECs did not contain insulin, after 4 days of INGAP 104-118 treatment, the total insulin content of ILS compared favorably to that found in freshly isolated islets (523751 versus 493752 ng insulin/mg DNA, respectively, Figure 6a ). Likewise, glucose-stimulated insulin secretion in ILS was indistinguishable from that of freshly isolated islets, both returning to baseline levels after the hyperglycemic stimulus was removed (Figure 6b ). These results indicate that this in vitro model can be used to produce functional islet tissue that displays high insulin content with appropriate glucose-regulated insulin secretion.
ILS develop from CK-19
þ cells within the DECs (Figure 7 ).
PI3-K pathway, but not ERK, is required for INGAP-induced DEC-to-ILS transformation
Our previous work established that islet-to-DEC transformation is associated with a carefully orchestrated sequence of signal transduction events in which a wave of JNK-1/2 phosphorylation and caspase-3 cleavage was implicated early in the onset of b-cell apoptosis, followed thereafter by an increase in ERK-1/2 and Akt phosphorylation that was associated with enhanced cellular proliferation and survival.
11
Given the importance of these signaling events in the islet-to-DEC phenotypic switch, we sought to determine their role, if any, during the time course of INGAP 104-118 -induced DEC-to-ILS transformation, using Western blot analysis. In comparison to untreated control cultures, JNK-1/2 phosphorylation was reduced by 47.978.1% (Figure 8a ) and caspase-3 To establish whether ERK and/or PI3-K pathways are essential for INGAP 104-118 -mediated ILS formation, pharmacological inhibitors of ERK kinase-1 and PI3-K were used. While previous reports have suggested that ERK-1/2 is a regulator of PDX-1 activation, 19 the inhibition of ERK-1/2 phosphorylation by PD98059 did not alter PDX-1 expression nor the ability of INGAP 104-118 to induce DEC-to-ILS transformation (Figure 8c) . Conversely, when PI3-K was inhibited by wortmannin, as evidenced by a lack of Akt phosphorylation, ILS did not form and islet cell hormones remained undetectable in the CK-19 þ cells comprising the DECs (Figure 8d ). These results suggest that the PI3-K signaling pathway is a necessary regulator of INGAP 104-118 -induced ILS formation, keeping with the known role of this pathway in normal islet development through its functional interaction with, and regulation of, PDX-1.
20,59,61,62
INGAP-induced ILS formation is accompanied by increased survival and decreased proliferation
To further clarify the functional consequences of these signal transduction events, changes in cell death and survival were examined by a programmed cell death-specific ELISA and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction, respectively, during the transition period from DEC-to-ILS. We determined that a 79.878.2% reduction in apoptosis (7.771.0 versus 1.670.3, A 405 nm /mg DNA) coincided with the increase in Akt and ERK-1/2 phosphorylation observed in INGAP 104-118 -treated cultures compared to -untreated controls, and that this was associated with the reduction in JNK-1/2 phosphorylation and caspase-3 cleavage (Figure 8a and b) . Moreover, the decrease in cell death was accompanied by a 41. 
Discussion
In this paper, we report that adult human islets of Langerhans retain an inherent morphogenetic plasticity that is indicated by their potential to revert back, in a developmental sense, to a primitive duct-like epithelial cystic state from which endocrine redifferentiation can be induced. While we and others have made similar observations concerning the cystic transformation of islets both in vitro 7, 8, 10, 11 and in vivo, 14 this is the first report of redifferentiation from the transformed cystic state back to endocrine cell clusters that resemble freshly isolated The plasticity of pancreatic tissues has perhaps best been demonstrated by the ability of acinar and ductal tissue to form new islets in vivo 63, 64 and in vitro, 25, [65] [66] [67] [68] [69] but the mechanisms and exact cell types involved are not known. Moreover, islets produced in vitro do not display normal endocrine gene expression, insulin content or physiologic glucose-responsive insulin secretion. 38, [65] [66] [67] [68] Is the morphologic switch from a solid mass of differentiated cells to a hollow epithelial cystic structure an unexpected observation or does it perhaps represent a default pathway that results in the 'reprogramming' of a differentiated cell mass as a means of ultimately achieving a substantial augmentation of function? Certainly, there is precedent in developmental biology 70 for the conversion of a solid structure to a cavitary one and for implicating the cystic state as a developmentally plastic transitional stage that serves to direct cell expansion and tissue differentiation. In this regard, dedifferentiated structures have also been implicated as developmentally plastic transitional structures that serve to direct cell expansion and tissue differentiation in numerous species 71, 72 including humans. 73 In keeping with these previous findings, the switch from islet to DEC is associated with upregulated expression of markers associated with stemness [48] [49] [50] [51] [52] including CD34, ABCG2, a-fetoprotein, b-galactosidase, PYY, nestin and NGN-3. Stocum has introduced the concept of regeneration competence 46 to describe adult cells that can be induced to regenerate the body's own tissues. Thus, the enhanced expression of stemness markers provides a genetic basis for the regeneration competence of DECs.
In this regard, the development of duct-like epithelial cells from hormone-producing endocrine cells appears to be the reverse of the normal process of islet formation during pancreatic organogenesis, in which it is accepted that primitive islets are formed from duct-like structures. 2 We propose four possible mechanisms by which the phenotypic switch from solid islet to cystic duct-like structure occurs in our model. First, the endocrine cells of the islet could undergo direct transformation to an epithelial cell type (Figure 9a ) through a process of transdifferentiation, 74 in which one cell type converts to another cell type with or without proceeding through a cellular intermediate and with or without proliferation. The evidence in support of this explanation are the double-labeling immunofluorescence studies that are consistent with a direct switch from glucagon þ and somatostatin þ cells to ones that are glucagon þ /CK-19 þ and somatostatin þ / CK-19 þ (Figure 2c ) en route to cells that express CK-19 þ alone, as well as ultrastructural studies demonstrating the appearance of microvilli and endosecretory granules in the same cell (Figure 2b) . Second, the islet may contain a progenitor cell(s) that undergoes proliferation and eventually forms the lining cells of the new cystic structures as the endocrine cells die off during cystic transformation (Figure 9b ). This explanation would appear to be refuted by the evidence presented above in favor of direct transformation. However, we have recently identified a quiescent population of nestin À cells that may function as intraislet progenitors. 75 In contrast, Zulewski et al. 25 have identified a population of nestin þ cells within adult human islets that may also serve as endocrine progenitors. Similarly, Seaberg et al. 36 recently reported the identification of multipotent nestin þ /À precursor cells in the mouse pancreas. A third possibility is that a combination of both direct transformation and progenitor cell expansion is operative. In this scenario, the cells lining the emerging duct-like structure are derived both from hormone-secreting endocrine cells and putative progenitor cells (Figure 9c ). In support of this notion is the heterogeneity in staining for PDX-1 (Figure 3c ) and nestin (Figure 3d ) in DECs and the observation that neoislet formation appears to occur at discrete locations within these structures. The putative role of these cells as progenitors in our model is supported by reports of the infrequent appearance of PDX-1 þ /insulin À23,24 and nestin þ 76 endocrine progenitors in the regenerating pancreas. It is also noteworthy that fluorescein-labeled INGAP 104-118 localizes to specific cells in the DECs (Figure 10a ) that may be the sites where these putative progenitor are located.
As a fourth possibility, the endocrine cells could be the sole contributors to the emerging epithelial cyst, but associated with this duct-like structure is at least one progenitor cell that can give rise to a new islet upon appropriate stimulation (Figure 9d) .
Confounding the issue is whether an adult b-cell progenitor exists at all. 37 While the argument against the existence of an adult b-cell progenitor has been advanced using a rodent model, 37 this has recently been disputed by Seaberg et al.
36
Moreover, Butler et al. 77, 78 have shown that the mechanism for islet expansion is likely to differ between mice and humans. Taken together, these observations suggest that existing assumptions about the dynamics of the postnatal islet differentiation process may require revision, underlining the need for an appropriate model of adult human pancreatic plasticity to study this process.
Notwithstanding the mechanism underlying islet-to-DEC transformation, the demonstration that NGN-3 þ DECs can differentiate to islets is in keeping with the observation of Gu et al. 21 that during pancreatic development islet neogenesis occurs from NGN-3-expressing duct-like structures. Our observation of the association between PI3-K signaling and INGAP [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] -induced islet formation takes on added importance in this regard because Akt1, a downstream effector of PI3-K, is a regulator of NGN-3 expression. 28 In preliminary studies, Akt1 expression and total Akt phosphorylation are increased significantly upon INGAP [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] -induced DEC-to-ILS transformation, as determined by Western blot (Figure 8d ). This result is in keeping with previous reports suggesting that Akt1 plays a critical role in b-cell growth and survival. 61, 62 In contrast, Akt2 and Akt3 were not detected in DECs or ILS (Figure 8d ). Transgenic mice deficient in SK61, another kinase downstream of PI3-K, display reduced b-cell mass and hypoinsulinemia, 79 providing further support for the importance of the PI3-K signaling pathway in b-cell phenotype and survival.
As the future of b-cell replacement therapies moves from conventional human cadaveric islet transplantation to that of ex vivo cellular expansion and transplantation, and endogenous progenitor cell therapies, 58 a more informed understanding of islet neogenesis will be required to permit both the optimization and control of islet expansion. Here, we report that adult human islets retain an inherent potential to revert back to a duct-like state from which endocrine redifferentiation, accompanied by the formation of new islets that exhibit glucose-responsive insulin secretion similar to freshly isolated islets, can occur. Moreover, our early experience with attempting to scale-up this process suggests the possibility of increasing b-cell mass by at least 2.5-fold, as determined by total insulin þ area compared to starting islet cultures (Figure 10b ). Taken together, this model of islet plasticity provides an opportunity to investigate the underlying regulatory mechanisms implicated in the development of functional adult islets as well as pancreatic adenocarcinomas and to characterize the intervening transitional cell types, thereby setting the stage for the translation of these provocative findings to a clinical setting.
Materials and Methods
Human islet isolation and culture
All experiments were approved by the Institutional Review Board of McGill University. Pancreata from adult human cadaveric organ donors were obtained through the local organ procurement organization. Islets were isolated according to established protocols. 80 Briefly, following removal of the organ, cold ischemia time was no more than 8 h prior to islet isolation. The main pancreatic duct was cannulated and perfused with Liberase HI (Roche Diagnostics, Montreal, QC, Canada). The perfused organ was placed in a closed system (Ricordi Apparatus) and heated to 371C to activate the enzyme blend. Following the appearance of free islets in samples, the system was cooled and free tissues were collected and washed. Tissues were applied to a continuous density gradient created using Ficoll (Biochrom KG, Berlin, Germany) in a cell processor (COBE). Free islets with diameters ranging from 75 to 400 mm, determined to be greater than 90% pure by staining with dithizone (Sigma, St Louis, MO, USA), a zinc chelater, were collected and washed. IHC to detect the presence of amylase and cytokeratin was negative, consistent with the absence of ductal and exocrine tissue.
Isolated islets were embedded in a type I collagen matrix at a density of 2000 islet equivalents/25 cm 2 and cultured in DMEM/F12 containing 10% FBS, 1 mM dexamethasone, 10 ng/ml EGF, 24 mU/ml insulin and 100 ng/ ml cholera toxin. 11 The medium was changed every other day. On day 10, solid spheroid islets had transformed into DECs. Culture was continued in the above medium, without cholera toxin, with neogenic agents and inhibitors at the final concentrations listed below. The medium was changed every other day. Collagen-embedded cultures were harvested by incubating with 0.25 g/l collagenase XI (Sigma) for 30 min at 371C.
INGAP [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] was added to DEC cultures at a concentration of 167 nM based on dose-response testing. GLP-1 and exendin-4 (Sigma) were used at 10, 50 and 167 nM. PD98059 (Calbiochem, San Diego, CA, USA), an ERK kinase-1 inhibitor, was used at 50 mM. Wortmannin (Sigma), a 
IHC, immunofluorescence and electron microscopy
Tissue was fixed in 4% paraformaldehyde and embedded in 3% agarose following a standard protocol of dehydration and paraffin embedding. 81 Serial sections (4 mm thickness) were cut from each paraffin block and processed for routine histology prior to sequential incubation with primary and biotinylated secondary antibodies. Signals were visualized using the AB complex method (streptavidin-biotin horseradish peroxidase; VectaStain, Toronto, ON, Canada), before counterstaining with hematoxylin and coverslipping. Tissues were probed with primary antibodies directed against insulin, glucagon, somatostatin and pancreatic polypeptide (1 : 100, Biogenex, San Ramon, CA, USA); CK-19 (1 : 100, Dako Cytomation, Mississauga, ON, Canada); PDX-1 (1 : 250, generous gift of C Wright); nestin (1 : 500, Cedarlane, Hornby, ON, Canada), C-peptide (1 : 1000, Cedarlane); GLUT-2 (1 : 50, R&D Systems, Minneapolis, MN, USA) and BrdU (1 : 500, Sigma). For immunofluorescence, slides were prepared as above, with the exception that fluorophore-linked secondary antibodies (Cedarlane) were employed.
Electron microscopy was performed upon transitional islet-DEC samples as indicated previously. 7 
Evaluation of cell death, survival and proliferation
Cell death was assessed using a cell death detection ELISA (Roche Diagnostics) as per the manufacturer's recommendations. Variations in sample size were corrected for by measuring total sample DNA content and standardizing between samples. 81 To determine which subpopulations of cells were undergoing apoptotic cell death, tissue samples were prepared as above for IHC and a TUNEL assay was performed with an in situ cell death detection kit (Roche Diagnostics) before continuing with the IHC protocol.
In order to determine cellular survival, equal samples were incubated with 1 mg/ml MTT (Sigma) for 2 h 371C. Pellets were washed twice with PBS before lysis with DMSO (Sigma). Absorbance was measured at 595 nm using a Benchmark Microplate Reader (Bio-Rad, Hercules, CA, USA) and expressed as the number of viable cells compared to the initial control.
To determine cell proliferation, cultures were incubated with 10 mM BrdU (Sigma) for 3 h. Cells were processed for IHC as above, and stained with an anti-BrdU antibody (Sigma). To calculate BrdU labeling, at least 500 cells were counted from each time point.
Insulin content and glucose responsiveness
Samples were processed for assessment of total insulin content using an insulin ELISA (Alpco Diagnostics) as per the manufacturer's specifications. Results were normalized to sample DNA content.
Following isolation and removal from collagen, islets, DECs and ILS were washed in glucose-free RPMI-1640 with 0.5% BSA and incubated for 1 h each with RPMI-1640 containing, sequentially, 2.2 mM glucose, 22 mM glucose, 22 mM glucose and 50 mM IBMX (Sigma), and finally 2.2 mM glucose. Insulin content of conditioned media was determined as above and values were normalized to sample DNA content.
Statistics
All results are displayed as mean7S.E.M. Results were determined to be significant at Po0.05.
